Squarepoint Ops LLC purchased a new position in Tempus AI, Inc. (NASDAQ:TEM – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 18,082 shares of the company’s stock, valued at approximately $633,000.
Other institutional investors also recently added to or reduced their stakes in the company. Sandia Investment Management LP bought a new stake in Tempus AI during the 2nd quarter valued at $136,000. Northwestern University bought a new stake in shares of Tempus AI in the second quarter valued at about $491,000. WINTON GROUP Ltd purchased a new stake in Tempus AI in the second quarter worth about $634,000. EFG Asset Management North America Corp. bought a new position in Tempus AI during the 2nd quarter worth about $1,333,000. Finally, Fred Alger Management LLC purchased a new position in Tempus AI during the 2nd quarter valued at about $2,167,000.
Wall Street Analysts Forecast Growth
TEM has been the subject of several research reports. JPMorgan Chase & Co. upped their price target on shares of Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Piper Sandler began coverage on Tempus AI in a research report on Monday, August 12th. They set a “neutral” rating and a $40.00 target price on the stock. TD Cowen started coverage on Tempus AI in a research report on Tuesday, July 9th. They issued a “buy” rating and a $50.00 price target for the company. Needham & Company LLC restated a “buy” rating and set a $47.00 price objective on shares of Tempus AI in a research note on Wednesday, August 7th. Finally, William Blair started coverage on Tempus AI in a research note on Tuesday, July 9th. They issued an “outperform” rating on the stock. Two equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Tempus AI has an average rating of “Moderate Buy” and a consensus price target of $47.67.
Tempus AI Stock Performance
Shares of NASDAQ:TEM opened at $48.08 on Wednesday. The business has a 50-day moving average price of $50.99. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $77.00. The company has a debt-to-equity ratio of 4.50, a current ratio of 3.70 and a quick ratio of 3.52.
Tempus AI (NASDAQ:TEM – Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The business had revenue of $165.97 million during the quarter, compared to the consensus estimate of $159.10 million. Analysts forecast that Tempus AI, Inc. will post -6.51 EPS for the current year.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Stories
- Five stocks we like better than Tempus AI
- Best Aerospace Stocks Investing
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- Pros And Cons Of Monthly Dividend Stocks
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- How to Effectively Use the MarketBeat Ratings Screener
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM – Free Report).
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.